PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
30-Sep-2024 NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID AccessWire
30-Sep-2024 Antimicrobial Dressing Market Thrives on Rising Demand for Effective Post-Surgical Care Pristine Market Insights
30-Sep-2024 Genflow Biosciences PLC Announces Half-year Report AccessWire
30-Sep-2024 T2D.com Announces That Former NFL Linebacker Alec Ogletree Has Joined the Company as a Co-Founder AccessWire
28-Sep-2024 Quantum Biopharma Provides Corporate Update AccessWire
27-Sep-2024 Ensysce Biosciences Receives Notice from Nasdaq AccessWire
27-Sep-2024 POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM) AccessWire
27-Sep-2024 MasterWord and UNESCO Join Forces to Preserve and Digitize Mayan Languages for Future Generations AccessWire
27-Sep-2024 Sorevna Introduces Revolutionary All-Natural Skin Cream for Tough Calluses and Dry Skin AccessWire
27-Sep-2024 Hyivy Health Secures $2M Seed to Unlock New Model for Treating Pelvic Pain AccessWire
27-Sep-2024 Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3 AccessWire
27-Sep-2024 Introducing Compassion Center Austin: Pioneering Natural Wellness Solutions Through the Texas Compassionate Use Program (TCUP) AccessWire
27-Sep-2024 Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion AccessWire
27-Sep-2024 MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 AccessWire
27-Sep-2024 Diabetic Gastroparesis Treatment Market: Rising Demand Sparks Innovation and Research Pristine Market Insights
27-Sep-2024 Hemogenyx Pharmaceuticals PLC Announces Half-year Report AccessWire
27-Sep-2024 enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering AccessWire
26-Sep-2024 Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results AccessWire
26-Sep-2024 enVVeno Medical Corporation Announces Proposed Public Offering AccessWire
26-Sep-2024 Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday AccessWire